Steve is a Registered Pharmacist and received his Pharmacy degree from Drake University. He then pursued graduate studies in Pharmacology and received a PhD from the College of Medicine at the University of Illinois. Steve became a postdoctoral fellow in Pharmacology at the University of Kentucky, College of Medicine from, later becoming a Research Associate in Veterinary Sciences. His research at the time focused on in vivo neuropharmacology of pain transmission and opioid and nicotine pharmacology. Subsequently, Steve joined the faculty of the School of Veterinary Medicine at Louisiana State University and achieved the rank of Endowed Professor at the time of his departure. He subsequently joined the Pharmacia & Upjohn Company (later becoming Pfizer then Zoetis) to pursue a career in drug discovery and has continued in that capacity since 1999. Steve is currently Therapeutic Area Head of Pain & Inflammation, Oncology, Cardiac Disease and Oncology. Steve’s research interests include animal models of pain, arthritis, inflammation, heart disease and the pharmacology of novel analgesics, NSAIDs, opioids and sedatives. He has also been active in evaluating novel, molecularly targeted therapeutics in spontaneous canine neoplasias, from a translational medicine perspective. Steve enjoys playing jazz guitar and singing in his free time.

Steve is a Registered Pharmacist and received his Pharmacy degree from Drake University. He then pursued graduate studies in Pharmacology and received a PhD from the College of Medicine at the University of Illinois. Steve became a postdoctoral fellow in Pharmacology at the University of Kentucky, College of Medicine from, later becoming a Research Associate in Veterinary Sciences. His research at the time focused on in vivo neuropharmacology of pain transmission and opioid and nicotine pharmacology. Subsequently, Steve joined the faculty of the School of Veterinary Medicine at Louisiana State University and achieved the rank of Endowed Professor at the time of his departure. He subsequently joined the Pharmacia & Upjohn Company (later becoming Pfizer then Zoetis) to pursue a career in drug discovery and has continued in that capacity since 1999. Steve is currently Therapeutic Area Head of Pain & Inflammation, Oncology, Cardiac Disease and Oncology. Steve’s research interests include animal models of pain, arthritis, inflammation, heart disease and the pharmacology of novel analgesics, NSAIDs, opioids and sedatives. He has also been active in evaluating novel, molecularly targeted therapeutics in spontaneous canine neoplasias, from a translational medicine perspective. Steve enjoys playing jazz guitar and singing in his free time.

Steve is a Registered Pharmacist and received his Pharmacy degree from Drake University. He then pursued graduate studies in Pharmacology and received a PhD from the College of Medicine at the University of Illinois. Steve became a postdoctoral fellow in Pharmacology at the University of Kentucky, College of Medicine from, later becoming a Research Associate in Veterinary Sciences. His research at the time focused on in vivo neuropharmacology of pain transmission and opioid and nicotine pharmacology. Subsequently, Steve joined the faculty of the School of Veterinary Medicine at Louisiana State University and achieved the rank of Endowed Professor at the time of his departure. He subsequently joined the Pharmacia & Upjohn Company (later becoming Pfizer then Zoetis) to pursue a career in drug discovery and has continued in that capacity since 1999. Steve is currently Therapeutic Area Head of Pain & Inflammation, Oncology, Cardiac Disease and Oncology. Steve’s research interests include animal models of pain, arthritis, inflammation, heart disease and the pharmacology of novel analgesics, NSAIDs, opioids and sedatives. He has also been active in evaluating novel, molecularly targeted therapeutics in spontaneous canine neoplasias, from a translational medicine perspective. Steve enjoys playing jazz guitar and singing in his free time.

Steve is a Registered Pharmacist and received his Pharmacy degree from Drake University. He then pursued graduate studies in Pharmacology and received a PhD from the College of Medicine at the University of Illinois. Steve became a postdoctoral fellow in Pharmacology at the University of Kentucky, College of Medicine from, later becoming a Research Associate in Veterinary Sciences. His research at the time focused on in vivo neuropharmacology of pain transmission and opioid and nicotine pharmacology. Subsequently, Steve joined the faculty of the School of Veterinary Medicine at Louisiana State University and achieved the rank of Endowed Professor at the time of his departure. He subsequently joined the Pharmacia & Upjohn Company (later becoming Pfizer then Zoetis) to pursue a career in drug discovery and has continued in that capacity since 1999. Steve is currently Therapeutic Area Head of Pain & Inflammation, Oncology, Cardiac Disease and Oncology. Steve’s research interests include animal models of pain, arthritis, inflammation, heart disease and the pharmacology of novel analgesics, NSAIDs, opioids and sedatives. He has also been active in evaluating novel, molecularly targeted therapeutics in spontaneous canine neoplasias, from a translational medicine perspective. Steve enjoys playing jazz guitar and singing in his free time.

Steve is a Registered Pharmacist and received his Pharmacy degree from Drake University. He then pursued graduate studies in Pharmacology and received a PhD from the College of Medicine at the University of Illinois. Steve became a postdoctoral fellow in Pharmacology at the University of Kentucky, College of Medicine from, later becoming a Research Associate in Veterinary Sciences. His research at the time focused on in vivo neuropharmacology of pain transmission and opioid and nicotine pharmacology. Subsequently, Steve joined the faculty of the School of Veterinary Medicine at Louisiana State University and achieved the rank of Endowed Professor at the time of his departure. He subsequently joined the Pharmacia & Upjohn Company (later becoming Pfizer then Zoetis) to pursue a career in drug discovery and has continued in that capacity since 1999. Steve is currently Therapeutic Area Head of Pain & Inflammation, Oncology, Cardiac Disease and Oncology. Steve’s research interests include animal models of pain, arthritis, inflammation, heart disease and the pharmacology of novel analgesics, NSAIDs, opioids and sedatives. He has also been active in evaluating novel, molecularly targeted therapeutics in spontaneous canine neoplasias, from a translational medicine perspective. Steve enjoys playing jazz guitar and singing in his free time.